Foresite Capital Fund VI LP - 31 Dec 2025 SCHEDULE 13G/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares, par value $0.0001 (CASI)

Filing Manager
Foresite Capital Fund VI LP
Reporting Manager
Foresite Capital Fund VI LP
Security
CASI Pharmaceuticals, Inc. Ordinary Shares, par value $0.0001
Symbol
CASI
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 18:03:48 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foresite Capital Fund VI LP 0% 0 0 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management VI LLC 0% 0 0 0 /s/ James Tananbaum James Tananbaum, Managing Member
James Tananbaum 0% 0 0 0 /s/ James Tananbaum James Tananbaum